C1 Inhibitor Use May Safely Prevent HAE Attacks in Pregnant Women

C1 Inhibitor Use May Safely Prevent HAE Attacks in Pregnant Women

287317

C1 Inhibitor Use May Safely Prevent HAE Attacks in Pregnant Women

Subcutaneous (under-the-skin) administration of human plasma-derived C1 inhibitor is an effective and safe option for managing hereditary angioedema during pregnancy and lactation, a case report suggests. The study, “Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE,” was published in the journal Clinical Case Reports. HAE is a rare genetic condition mainly caused by mutations in the gene that holds the instructions for the C1 inhibitor (C1-IHN) protein. In HAE…

You must be logged in to read/download the full post.